Abstract
Dysregulated expression of the homeobox gene, HOX11 is a frequent etiologic event in T-cell acute lymphoblastic leukemias. HOX11-transgenic mice (IgHμ-HOX11Tg)-expressing HOX11 in the B-cell compartment develop B-cell lymphomas with extended latency. The latency suggests that additional genetic events are required prior to the onset of malignant lymphoma. We report the identification of 17 HOX11 collaborating genes, revealed through their propensity to be targeted in a proviral insertional mutagenesis screen. Seven integrations disrupted genes in mitotic spindle checkpoint control, suggesting that cells with elevated HOX11 expression are especially sensitive to dysregulation of chromosome segregation during mitosis. IgHμ-HOX11Tg primary B-lymphocyte cultures exposed to the aneugenic agents, colchicine and colcemid, exhibited increased incidences of chromosome missegregation as assessed by cytokinesis-block micronucleus assays. Additionally, IgHμ-HOX11Tg cultures were shown to exhibit aberrant bypass of spindle checkpoint arrest, as assessed by the increased presence of cycling cells determined by assessment of DNA content and by BrdU immunolabelling. Western immunoblotting revealed elevated expression of the mitotic effector molecules, cyclin A, cyclin B1 and cdc20 in IgHμ-HOX11Tg cultures. Moreover, spontaneously arising lymphoid neoplasms in IgHμ-HOX11Tg mice frequently exhibit aberrant expression of mitotic regulators, concomitant with increased development of micronuclei, abnormal mitotic checkpoint control and increased incidences of abnormal karyotypes when expanded in culture. Collectively, these findings indicate that abnormal regulation of spindle checkpoint control as a result of HOX11 overexpression leads to a heightened predisposition for development of aneuploidy, contributing to oncogenesis.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Akagi K, Suzuki T, Stephens RM, Jenkins NA, Copeland NG . (2004). Nucl Acids Res 32: D523–D527.
Asnafi V, Beldjord K, Libura M, Villarese P, Millien C, Ballerini P et al. (2004). Blood 104: 4173–4180.
Asnafi V, Buzyn A, Thomas X, Huguet F, Vey N, Boiron JM et al. (2005). Blood 105: 3072–3078.
Aziz DC, Hanna Z, Jolicoeur P . (1989). Nature 338: 505–508.
Berns A . (1991). J Cell Biochem 47: 130–135.
Bourner RD, Parry EM, Parry JM . (1998). Mutat Res 404: 191–197.
Casabianca A, Orlandi C, Fraternale A, Magnani M . (2003). J Virol Methods 110: 81–90.
Chattopadhyay SK, Morse HC, Makino III M, Ruscetti SK, Hartley JW . (1989). Proc Natl Acad Sci USA 86: 3862–3866.
Diamond RA, DeMaggio S (eds). Living Color: Protocols in Flow Cytometry and Cell Sorting, Springer Lab Manual. Springer: Berlin, 2000.
Dubé ID, Kamel-Reid S, Yuan CC, Lu M, Wu X, Corpus G et al. (1991). Blood 78: 2996–3003.
Dubé ID, Raimondi SC, Pi D, Kalousek DK . (1986). Blood 67: 1181–1184.
Erkeland SJ, Valkhof M, Heijmans-Antonissen C, van Hoven-Beijen A, Delwel R, Hermans MH et al. (2004). J Virol 78: 1971–1980.
Ferrando AA, Neuberg DS, Dodge RK, Paietta E, Larson RA, Wiernik PH et al. (2004). Lancet 363: 535–536.
Ferrando AA, Neuberg DS, Staunton J, Loh ML, Huard C, Raimondi SC et al. (2002). Cancer Cell 1: 75–87.
Hough MR, Reis MD, Singaraja R, Bryce DM, Kamel-Reid S, Dardick I et al. (1998). Proc Natl Acad Sci USA 95: 13853–13858.
Huang M, Simard C, Jolicoeur P . (1989). Science 246: 1614–1617.
Huang M, Simard C, Jolicoeur P . (1992). J Virol 66: 2398–2406.
Huang M, Simard C, Kay DG, Jolicoeur P . (1991). J Virol 65: 6562–6571.
Huang M, Takac M, Kozak CA, Jolicoeur P . (1995). J Virol 69: 4069–4078.
Hwang HC, Martins CP, Bronkhorst Y, Randel E, Berns A, Fero M et al. (2002). Proc Natl Acad Sci USA 99: 11293–11298.
Iwasaki M, Kuwata T, Yamazaki Y, Jenkins NA, Copeland NG, Osato M et al. (2004). Blood 105: 784–793.
Jonkers J, Berns A . (1996). Biochim Biophys Acta 1287: 29–57.
Kawabe T, Muslin AJ, Korsmeyer SJ . (1997). Nature 385: 454–458.
Kees UR, Heerema NA, Kumar R, Watt PM, Baker DL, La MK et al. (2003). Leukemia 17: 887–893.
Kim R, Trubetskoy A, Suzuki T, Jenkins NA, Copeland NG, Lenz J . (2003). J Virol 77: 2056–2062.
Laoukili J, Kooistra MR, Bras A, Kauw J, Kerkhoven RM, Morrison A et al. (2005). Nat Cell Biol 7: 126–136.
Li J, Shen H, Himmel KL, Dupuy AJ, Largaespada DA, Nakamura T et al. (1999). Nat Genet 23: 348–353.
Lichty BD, Ackland-Snow J, Noble L, Kamel-Reid S, Dube ID . (1995). Leuk Lymphoma 16: 209–215.
Mauvieux L, Leymarie V, Helias C, Perrusson N, Falkenrodt A, Lioure B et al. (2002). Leukemia 16: 2417–2422.
Morse HC, Anver III MR, Fredrickson TN, Haines DC, Harris AW, Harris NL et al. (2002). Blood 100: 246–258.
Muehlbauer PA, Schuler MJ . (2005). Mutat Res 585: 156–169.
Rao H, Uhlmann F, Nasmyth K, Varshavsky A . (2001). Nature 410: 955–959.
Riz I, Hawley RG . (2005). Oncogene 14: 5561–5575.
Rosic-Kablar S, Chan K, Reis MD, Dube ID, Hough MR . (2000). Proc Natl Acad Sci USA 97: 13300–13305.
Shin MS, Fredrickson TN, Hartley JW, Suzuki T, Agaki K, Morse III HC . (2004). Cancer Res 64: 4419–4427.
Varshavsky A . (1996). Proc Natl Acad Sci USA 93: 12142–12149.
Acknowledgements
We gratefully acknowledge the staff of the Sunnybrook Animal Care Unit for excellent assistance with animal husbandry. We thank Drs Daniel Dumont and Jorge Filmus for critical reading of this manuscript and for helpful discussions. EC is an Ontario Graduate Scholar in Science and Technology. This work was supported by funding from the National Cancer Institute of Canada (#13309) to MRH.
Author information
Authors and Affiliations
Corresponding author
Additional information
Supplementary Information accompanies the paper on Oncogene website (http://www.nature.com/onc)
Supplementary information
Rights and permissions
About this article
Cite this article
Chen, E., Lim, M., Rosic-Kablar, S. et al. Dysregulated expression of mitotic regulators is associated with B-cell lymphomagenesis in HOX11-transgenic mice. Oncogene 25, 2575–2587 (2006). https://doi.org/10.1038/sj.onc.1209285
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1209285
Keywords
This article is cited by
-
A novel TLX1-driven T-ALL zebrafish model: comparative genomic analysis with other leukemia models
Leukemia (2020)
-
Phosphorylation of HOX11/TLX1 on Threonine-247 during mitosis modulates expression of cyclin B1
Molecular Cancer (2010)
-
The T-ALL paradox in cancer
Nature Medicine (2010)
-
The TLX1 oncogene drives aneuploidy in T cell transformation
Nature Medicine (2010)
-
Loss of Ubr1 promotes aneuploidy and accelerates B-cell lymphomagenesis in TLX1/HOX11-transgenic mice
Oncogene (2006)